Shilpa Medicare shares rose today after the company secured GMP certification from Saudi Arabia's SFDA for its Unit VI ...

Shilpa Medicare's Unit VI facility, located at Dabaspet, Bengaluru, Karnataka, has received SFDA, Saudi Arabia, GMP certification.

Karnataka: Shilpa Medicare has announced that its Unit VI facility, located at Dabaspet, Bengaluru, Karnataka, has received ...

Trump’s tax bill could reshape drug R&D, manufacturing, Medicaid access, clinical trials, and biotech funding, impacting ...

RITI announced today that its flagship testosterone booster for men now features 150 mg of KSM-66® Ashwagandha root extract, standardized to 2.5 % withanolides, per serving. The enhancement arrives ...

The US Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity disorder (ADHD) medications.

The Food and Drug Administration (FDA) has updated the labeling for Kisunla ™ (donanemab-azbt) to include a new recommended titration dosing schedule for adults with early symptomatic Alzheimer ...